Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD-Reference-Cited by-同舟云学术

Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD

Published:2009-10 Issue:10 Volume:30 Page:1449-1459
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

de Greef Jessica C.,Lemmers Richard J.L.F.,van Engelen Baziel G.M.,Sacconi Sabrina,Venance Shannon L.,Frants Rune R.,Tawil Rabi,van der Maarel Silvère M.

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference47 articles.

1. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter;Bakker;Muscle Nerve,1995

2. DXZ4 chromatin adopts an opposing conformation to that of the surrounding chromosome and acquires a novel inactive X-specific role involving CTCF and antisense transcripts;Chadwick;Genome Res,2008

3. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes;Celegato;Proteomics,2006

4. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD;de Greef;Neurology,2007

5. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4;Deak;Neurology,2007

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Trouble: A Comprehensive Study Into Unrelated Genetic Comorbidities in Adult Patients with Facioscapuluhumeral Muscular Dystrophy Type I;2024-09-12

2. French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD);Journal of Neurology;2024-07-02

3. Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation;iScience;2024-04

4. IL-6 and TNF are Potential Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy;Journal of Neuromuscular Diseases;2024-03-05

5. Muscular Dystrophy: Underlying Cellular and Molecular Mechanisms and Various Nanotherapeutic Approaches for Muscular Dystrophy;Mechanism and Genetic Susceptibility of Neurological Disorders;2024